1. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ
- Author
-
Nico de Vogel, Frans J. Kok, Geert van Poppel, and Peter J. van Balderen
- Subjects
Adult ,Male ,Nicotine ,Cancer Research ,medicine.medical_specialty ,Chromatography, Gas ,DNA damage ,Lymphocyte ,Enzyme-Linked Immunosorbent Assay ,Sister chromatid exchange ,Biology ,chemistry.chemical_compound ,Internal medicine ,medicine ,Humans ,Lymphocytes ,Lung cancer ,Glutathione Transferase ,Smoking ,General Medicine ,Glutathione ,medicine.disease ,Molecular biology ,respiratory tract diseases ,Isoenzymes ,medicine.anatomical_structure ,Endocrinology ,Glutathione S-transferase ,chemistry ,Toxicity ,biology.protein ,Cotinine ,Sister Chromatid Exchange ,DNA Damage - Abstract
Reduced expression of the mu-isozyme of glutathione S-transferase (GST; EC 2.5.1.18) has been associated with increased lung cancer risk. We studied the association between GST-mu expression and DNA damage as measured by sister chromatid exchanges (SCE) in healthy male smokers. SCE levels were higher in the 71 GST-mu-deficient smokers compared to the 83 non-deficient smokers (5.24 versus 4.97 SCE/lymphocyte; P = 0.09). In smokers having high plasma cotinine levels (greater than median of 315 ng/ml), this mu-related difference was more pronounced (5.50 versus 4.97; P = 0.01), whereas it was absent in smokers having low cotinine levels (4.95 versus 4.97; P = 0.92). Increased cytogenetic damage in GST-mu-deficient heavy smokers may thus explain the association between GST-mu expression and lung cancer.
- Published
- 1992
- Full Text
- View/download PDF